Patrick J. Grohar, Ph.D.
Affiliations: | 2001 | Wayne State University, Detroit, MI, United States |
Area:
Biochemistry, Organic ChemistryGoogle:
"Patrick Grohar"Mean distance: 3619.36
Parents
Sign in to add mentorChristine S. Chow | grad student | 2001 | Wayne State | |
(Synthesis, investigation and application of modified nucleic acids.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Deng Q, Natesan R, Cidre-Aranaz F, et al. (2022) Oncofusion-driven de novo enhancer assembly promotes malignancy in Ewing sarcoma via aberrant expression of the stereociliary protein LOXHD1. Cell Reports. 39: 110971 |
Gedminas JM, Kaufman R, Boguslawski EA, et al. (2022) Lurbinectedin inhibits the EWS-WT1 transcription factor in desmoplastic small round cell tumor. Molecular Cancer Therapeutics |
Gedminas JM, Chasse MH, McBrairty M, et al. (2020) Desmoplastic small round cell tumor is dependent on the EWS-WT1 transcription factor. Oncogenesis. 9: 41 |
Flores G, Everett JH, Boguslawski EA, et al. (2020) CDK9 Blockade Exploits Context-Dependent Transcriptional Changes to Improve Activity and Limit Toxicity of Mithramycin for Ewing Sarcoma. Molecular Cancer Therapeutics |
Sissung TM, Huang PA, Hauke RJ, et al. (2019) Severe Hepatotoxicity of Mithramycin Therapy Caused by Altering Expression of Hepatocellular Bile Transporters. Molecular Pharmacology |
Bailey K, Cost C, Davis I, et al. (2019) Emerging novel agents for patients with advanced Ewing sarcoma: a report from the Children's Oncology Group (COG) New Agents for Ewing Sarcoma Task Force. F1000research. 8 |
Harlow ML, Chasse MH, Boguslawski EA, et al. (2019) Trabectedin Inhibits EWS-FLI1 and Evicts SWI/SNF from Chromatin in a Schedule Dependent Manner. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
Flores G, Kitchen-Goosen S, Oswald B, et al. (2019) Abstract 2882: Mithramycin impedes EWS-FLI1 driven transcription by preventing target promoter clearance Cancer Research |
Chasse MH, Boguslawski E, Sorensen K, et al. (2019) Abstract 2883: Mithramycin inhibits KDM6A (UTX) and SWI/SNF to induce apoptosis in malignant rhabdoid tumor Cancer Research. 79: 2883-2883 |
Chasse MH, Boguslawski EA, Sorensen KM, et al. (2018) Abstract A32: Therapeutically targeting PRC2 expression and dynamics in rhabdoid tumor Cancer Research. 78 |